These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 17052487)

  • 1. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
    Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
    J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.
    Conen D; Torres J; Ridker PM
    Circulation; 2008 Sep; 118(13):1321-7. PubMed ID: 18779441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of chronic plaque-type psoriasis in placebo groups of randomized controlled studies.
    Spuls PI; Witkamp L; Bossuyt PM; Bos JD
    Arch Dermatol; 2004 Mar; 140(3):338-44; discussion 344. PubMed ID: 15023777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH clinical trials and publication bias.
    Dickersin K; Min YI
    Online J Curr Clin Trials; 1993 Apr; Doc No 50():[4967 words; 53 paragraphs]. PubMed ID: 8306005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006.
    Naldi L; Svensson A; Zenoni D; Diepgen T; Elsner P; Grob JJ; Coenraads PJ; Bouwes Bavinck JN; Maccagni A; Linder D; Williams H;
    Br J Dermatol; 2010 Feb; 162(2):384-9. PubMed ID: 19785620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.
    Bero L; Oostvogel F; Bacchetti P; Lee K
    PLoS Med; 2007 Jun; 4(6):e184. PubMed ID: 17550302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.
    Rochon PA; Clark JP; Binns MA; Patel V; Gurwitz JH
    CMAJ; 1998 Aug; 159(4):321-7. PubMed ID: 9732709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.
    Rosenblatt M
    J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK
    J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
    Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
    CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International collaboration, funding and association with burden of disease in randomized controlled trials in Africa.
    Swingler GH; Pillay V; Pienaar ED; Ioannidis JP
    Bull World Health Organ; 2005 Jul; 83(7):511-7. PubMed ID: 16175825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between research sponsorship and study outcome in plastic surgery literature.
    Momeni A; Becker A; Bannasch H; Antes G; Blümle A; Stark GB
    Ann Plast Surg; 2009 Dec; 63(6):661-4. PubMed ID: 19887933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quality of clinical trials published in The Journal of Family Practice, 1974-1991.
    Sonis J; Joines J
    J Fam Pract; 1994 Sep; 39(3):225-35. PubMed ID: 8077901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
    Liyanage SS; Raina Macintyre C
    Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.